Pedersen, M.A.; Baad-Hansen, T.; Gormsen, L.C.; Bærentzen, S.; Sandfeld-Paulsen, B.; Aggerholm-Pedersen, N.; Vendelbo, M.H.
Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value. Cancers 2023, 15, 816.
https://doi.org/10.3390/cancers15030816
AMA Style
Pedersen MA, Baad-Hansen T, Gormsen LC, Bærentzen S, Sandfeld-Paulsen B, Aggerholm-Pedersen N, Vendelbo MH.
Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value. Cancers. 2023; 15(3):816.
https://doi.org/10.3390/cancers15030816
Chicago/Turabian Style
Pedersen, Mette Abildgaard, Thomas Baad-Hansen, Lars C. Gormsen, Steen Bærentzen, Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, and Mikkel Holm Vendelbo.
2023. "Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value" Cancers 15, no. 3: 816.
https://doi.org/10.3390/cancers15030816
APA Style
Pedersen, M. A., Baad-Hansen, T., Gormsen, L. C., Bærentzen, S., Sandfeld-Paulsen, B., Aggerholm-Pedersen, N., & Vendelbo, M. H.
(2023). Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value. Cancers, 15(3), 816.
https://doi.org/10.3390/cancers15030816